ARTICLE | Clinical News
Adult stem cells: Phase II start
October 31, 2011 7:00 AM UTC
On Nov. 8, Mesoblast will begin a placebo-controlled, Singaporean Phase II trial to compare a single intraocular injection of MPCs plus Lucentis ranibizumab vs. Lucentis alone in 18 newly-diagnosed wet AMD patients. ...